In an era in which there is a choice of effective therapy, a wide range of factors should be considered when selecting treatment, including overall tolerability profiles, ease of managing adverse events and costs associated with adverse event management.
Additional factors to be considered when defining multimorbidity include the severity of the conditions and the presence or absence of associated pain.
This paper discusses the principal data issues which must be considered when analysing hydrochemical datasets, including non-normality and non-stationarity.
Several factors need to be considered when employing extraction techniques including the solvent types and ratios, extraction temperatures, extraction times, and solid to liquid ratios to ensure a complete extraction of the compounds of interest, while avoiding chemical modification [31, 33 35].
Several caveats should be considered when interpreting these data, including the fact that these analyses were exploratory, with no attempt to correct for multiplicity.
However, various factors should be considered when estimating PON1 activity, including its cardioprotective properties, as well as age, gender, lifestyle, medical conditions and pharmacological agent [161].
Several potential limitations must be considered when using secondary HOD, including those related to evolving or changing diagnostic criteria, misclassification, generalizability, measurement error, and completeness.
Some limitations of the present study should be considered when interpreting the results including the reliability of the clinical measurements of malocclusion, such as the Index of Orthodontic Treatment Need (IOTN), and Angle's classification of malocclusion.
A number of significant methodological limitations should be considered when interpreting these findings, including the small number of respondents, as well as the subjective and retrospective nature of the survey data.
